NRXS

Neuraxis Inc

$4.86

+0.23 (+4.97%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 11.01.2026
$5.00
(+2.88%)
Strong Buy: 0
Buy: 2
Hold: 0
Sell: 0
Strong Sell: 0
Description:
Neuraxis, Inc. is a forward-thinking medical technology company located in Versailles, Indiana, specializing in the development of advanced neuromodulation therapy devices designed to address a range of neurological disorders. By harnessing innovative technologies and conducting thorough research, Neuraxis strives to deliver therapeutic solutions that significantly enhance patient outcomes and overall quality of life. With its focus on critical unmet medical needs, the company is well-positioned for substantial growth in the evolving neuromodulation market, making it an attractive prospect for institutional investors seeking to capitalize on advancements in healthcare technology.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
11611 NORTH MERIDIAN ST, CARMEL, IN, UNITED STATES, 46032
Fiscal year end:
December
Market capitalization:
$23.5 Million
EBITDA:
-$7.54 Million
PERatio:
0.0
EPS:
-1.05
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
3.164

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 2 years:
-24%
How much will you get:
$757
Prices dates:
09-08-2023: $6.00 and 31-12-2025: $4.54